These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 7047165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
    Kotlar HK, Sanner T.
    Cancer Lett; 1980 Nov; 11(1):11-9. PubMed ID: 7013972
    [Abstract] [Full Text] [Related]

  • 5. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO, Tataryn DN, MacFarlane JK, Thomson DM, Schwartz R.
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Humoral leukocyte adherence inhibition response in patients with oral cancer.
    Becher R, Kotlar HK, Sanner T.
    Scand J Dent Res; 1988 Aug; 96(4):347-52. PubMed ID: 3166199
    [Abstract] [Full Text] [Related]

  • 9. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ, Alexander NJ, Fulgham DL, Vandenbark AA, Burger DR.
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D, Kaufmann M, Drings P, Fedra G.
    Oncology; 1978 Sep; 35(6):242-5. PubMed ID: 370704
    [Abstract] [Full Text] [Related]

  • 11. Antigen specificity of squamous cancers of the head and neck based on tumor site using the slide leukocyte adherence inhibition assay.
    Taylor SG, Safford PC.
    J Surg Oncol; 1982 May; 20(1):41-5. PubMed ID: 6176812
    [Abstract] [Full Text] [Related]

  • 12. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
    McCoy JL, Jerome LF, Anderson C, Cannon GB, Alford TC, Connor RJ, Oldham RK, Herberman RB.
    J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
    [Abstract] [Full Text] [Related]

  • 13. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
    Thomson DM, Ayeni RO, MacFarlane JK, Tataryn DN, Terrin M, Schraufnagel D, Wilson J, Mulder DS.
    Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
    [Abstract] [Full Text] [Related]

  • 14. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer.
    Koide Y, Wakazono K, Yamagata K, Miyaji M, Yamamoto M.
    Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433
    [Abstract] [Full Text] [Related]

  • 15. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB, Dyer CA, Mortensen RF.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract] [Full Text] [Related]

  • 16. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ, Koppi TA, Khan JM, Davis NC.
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [Abstract] [Full Text] [Related]

  • 17. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S, Thuy LT, Pasternak G, Schlott B, Reinhöfer J, Lunow E, Loewe G, Gütz HJ.
    Acta Biol Med Ger; 1978 Aug; 37(11-12):1747-57. PubMed ID: 382722
    [Abstract] [Full Text] [Related]

  • 18. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
    Tsang PH, Roboz JP, Holland JF, Bekesi JG.
    Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
    [Abstract] [Full Text] [Related]

  • 19. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
    Tsang PH, Tangnavarad K, Lesnick G, Perloff M, Holland JF, Bekesi JG.
    J Immunol Methods; 1980 Jan; 36(2):119-35. PubMed ID: 7000908
    [Abstract] [Full Text] [Related]

  • 20. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M, Marti JH, Grosser N, MacFarlane JK, Thomson DM.
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.